274742 Lung Cancer Screening, the Intersection of Science, Epidemiology and Delivery

Monday, October 29, 2012 : 1:10 PM - 1:30 PM

Stephen Deppen, MA, MS , Vanderbilt University Medical Center, Nashville, TN
     
A number of clinical societies and patient advocacy groups recently published guidelines for lung cancer screening. The efficacy of screening may be weakened due to the specialized cancer care required for a successful screening program. Access to such care is limited for low income and rural populations. These populations are at greatest risk for lung cancer and would most benefit from a screening program. We examine how epidemiology, health policies in the Affordable Care Act and clinical science interact through the newly proposed lung cancer guidelines.

Learning Areas:
Epidemiology

Learning Objectives:
Explain the new lung cancer screening guidelines and how disparities in care may erode the strength of evidence for lung cancer screening.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have published in the areas of health care delivery, cost effectiveness, and translational epidemiology of cancer screening. My dissertation examines predicting lung cancer and variation of benign lung disease diagnosis across the US.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3228.0: The Practice of Epidemiology: Intersection of Science, Service, and Policy